Medicine

Teva Reports Positive Data from Anti-TL1A Antibody for Inflammatory Bowel Diseases

TEV-’574 has shown potential as a treatment for inflammatory bowel diseases such as ulcerative colitis and Crohn disease.

Leave a Reply

Your email address will not be published. Required fields are marked *